Showing results (301-310 of 320) with videos related to

Sort By:
Pageof 32
The Journal of Pathology|May 27, 2015
Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesotheliomaViktoria Laszlo, Mir Alireza Hoda, Tamas Garay, et al.
Journal of Personalized Medicine|April 30, 2021
Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal MelanomatosisAlicia Baumgartner, Natalia Stepien, Lisa Mayr, et al.
Neuro-Oncology|April 4, 2017
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gainJohannes Gojo, Daniela Lötsch, Sabine Spiegl-Kreinecker, et al.
Carcinogenesis|April 11, 2018
FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signalKarin Schelch, Christina Wagner, Sonja Hager, et al.
Cancer Research|October 30, 2025
Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic DiscoveryAleksandr Ianevski, Kristen Nader, Julia Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2020
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma SubgroupChristine Pirker, Agnes Bilecz, Michael Grusch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2016
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional studyMir Alireza Hoda, Yawen Dong, Anita Rozsas, et al.
Journal of Personalized Medicine|December 23, 2020
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade GliomaLisa Mayr, Armin S Guntner, Sibylle Madlener, et al.
Translational Lung Cancer Research|May 20, 2021
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter studyLuka Brcic, Thomas Klikovits, Zsolt Megyesfalvi, et al.
Acta Neuropathologica Communications|April 28, 2022
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasivenessLisa Gabler, Carola Nadine Jaunecker, Sonja Katz, et al.
Pageof 32